Objective: To analyze the contents of spontaneous comments posted by ecstasy users participating in an online survey that constitutes phase one of a harm reduction project (projeto Baladaboa) aimed at users of this drug.
Method: Of the 1,140 individual respondents, 412 posted unprompted comments. These comments were grouped into five categories (irrelevant, drugs, testimonies, survey, and project) and submitted to content analysis. Salutations, irreverent comments, and ideological remarks were considered "Irrelevant." Comments on the causes, effects, and consequences of using ecstasy or other drugs; requests for information on the drug; or comments indicating that information is a crucial issue associated with the use of ecstasy were labeled "Drugs." Personal stories made up the group called "Testimonies." Any comments concerning the questionnaire itself, the formulation of questions, the use of certain criteria, and requests to see survey results were designated "Survey." Comments specifically about the Baladaboa project were categorized as "Project".
Results: Content analysis revealed 915 segments among the 412 comments. The percent distribution of segments among the groups were: irrelevant, 9.8%; drugs, 16.4%; testimonies, 18.1%; survey, 25.1%; and project, 30.6%. Most of the comments concerning the survey and the project were positive.
Conclusions: The number and content of the spontaneous comments indicate that the project, as well as the harm reduction strategy, were being well received by the target audience. The participants expressed their engagement with the project and suggested that its continuation is both timely and urgent.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s1020-49892007001100004 | DOI Listing |
Chin Med J (Engl)
January 2025
Department of Surgery, University of Virginia, Charlottesville, Virginia 22903, USA.
Dig Liver Dis
January 2025
NEUROFARBA Department, University of Florence, viale Gaetano Pieraccini 6, 50139 Firenze, Italy; Meyer Children's Hospital IRCCS, viale Gaetano Pieraccini 24, 50139 Firenze, Italy.
Br J Anaesth
January 2025
Department of Anaesthesia, Monash Medical Centre, Melbourne, VIC, Australia.
Food Chem
January 2025
Poznań University of Technology, Institute of Chemistry and Technical Electrochemistry, Berdychowo 4, 60-965 Poznań, Poland. Electronic address:
Catechins, due to their high antioxidant capacity, are ones of the most common ingredients of human diet (e.g. tea, fruits, cacao) of the well-known health benefit properties.
View Article and Find Full Text PDFAm J Cardiovasc Drugs
January 2025
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Flurpiridaz F 18 (FLYRCADO™) is an intravenous (IV) radioactive diagnostic drug being developed by GE Healthcare and Lantheus Medical Imaging for use in positron emission tomography (PET) myocardial perfusion imaging (MPI) to detect coronary artery disease (CAD). In September 2024, flurpiridaz F 18 was approved in the USA for PET MPI under rest or stress (pharmacologic or exercise) in adult patients with known or suspected CAD to evaluate for myocardial ischemia and infarction. This article summarizes the milestones in the development of flurpiridaz F 18 leading to this first approval for use in PET MPI in adult patients to evaluate for myocardial ischemia and infarction.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!